Pricing Log in Create free account

Nordicus Partners Corporation (NORD) vs OKYO Pharma Limited Sponsored ADR (OKYO)

Nordicus Partners Corporation and OKYO Pharma Limited Sponsored ADR are both Biotechnology companies. Nordicus Partners Corporation and OKYO Pharma Limited Sponsored ADR are of similar size ($75.1M and $72.4M). Across the 10 metrics below, OKYO Pharma Limited Sponsored ADR leads on 6 and Nordicus Partners Corporation on 4.

Valuation

Metric NORD OKYO Biotechnology median
P/E n/m n/m 10.26
P/S 81.31 n/m 9.18
P/B 1.06 85.82 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 83.80 n/m 8.98
Earnings yield (8.24%) 0.00% (34.89%)
Free cash flow yield (6.25%) (0.90%) (24.52%)

Profitability

Metric NORD OKYO Biotechnology median
Gross margin 70.18% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (8.06%) 0.00% (50.12%)
Return on assets (6.80%) 0.00% (45.60%)
Return on invested capital (4.43%) 0.00% 0.00%

Growth

Metric NORD OKYO Biotechnology median
Revenue growth (TTM) (71.68%) — 6.26%
EPS growth (last fiscal year) 30.58% (101.34%) 29.88%
Revenue growth, 5-year CAGR (71.31%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NORD OKYO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.18 2.43 4.89
Net debt to EBITDA 0.00 2.42 1.01

Dividend

Metric NORD OKYO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NORD OKYO Biotechnology median
Market cap 72.43m 75.05m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack